Factor IX expression in skeletal muscle of a severe hemophilia B patient 10 years after AAV-mediated gene transfer

George Buchlis, Gregory M. Podsakoff, Antonetta Radu, +4

Blood

CCL2 Blockade Augments Cancer Immunotherapy

Zvi G. Fridlender, George Buchlis, Veena Kapoor, +8

Cancer Research

Monocyte Chemoattractant Protein–1 Blockade Inhibits Lung Cancer Tumor Growth by Altering Macrophage Phenotype and Activating CD8 ⁺ Cells

Zvi G. Fridlender, Veena Kapoor, George Buchlis, +6

American Journal of Respiratory Cell and Molecular Biology

Peripheral transvenular delivery of adeno-associated viral vectors to skeletal muscle as a novel therapy for hemophilia B

Valder R. Arruda, Hansell H. Stedman, Virginia Haurigot, +14

Blood

Systemic Blockade of Transforming Growth Factor-β Signaling Augments the Efficacy of Immunogene Therapy

Samuel Kim, George Buchlis, Zvi G. Fridlender, +10

Cancer Research

Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs

Virginia Haurigot, Federico Mingozzi, George Buchlis, +12

Molecular Therapy

High-dose systemic adeno-associated virus vector administration causes liver and sinusoidal endothelial cell injury

Juliette Hordeaux, Jason Lamontagne, Chunjuan Song, +9

Molecular Therapy

HepatologyLiver PhysiologyViral PathogenesisAntiviral TherapyPathology +6

Cardiac Gene Transfer of Short Hairpin RNA Directed Against Phospholamban Effectively Knocks Down Gene Expression but Causes Cellular Toxicity in Canines

Lawrence T. Bish, Meg M. Sleeper, Caryn Reynolds, +9

Human Gene Therapy

Cardiac MuscleHeart FailureGeneticsPathologyStructural Heart Disease +16

Modulation of CD8+ T cell responses to AAV vectors with IgG-derived MHC class II epitopes

Daniel J. Hui, Etiena Basner‐Tschakarjan, Yifeng Chen, +12

Molecular Therapy

Crucial Roles of TNFAIP8 Protein in Regulating Apoptosis and <i>Listeria</i> Infection

Thomas Porturas, Honghong Sun, George Buchlis, +7

The Journal of Immunology